U.S. Blood Pressure Monitors Market Size, Share & COVID-19 Impact Analysis, By Product (Sphygmomanometer, Digital BP Monitors, and Ambulatory BP Monitors), By End-user (Hospitals & Clinics, Home Healthcare, and Others), and Country Forecast, 2023-2030

The U.S. blood pressure monitors market size was worth USD 602.4 million in 2022 and is projected to grow at a CAGR of 9.1% during the forecast period.

A blood pressure monitor helps to assess the fluctuations in blood pressure, which can help detect hypertension and other cardiovascular diseases. Moreover, hypertension can lead to heart disease and stroke if not diagnosed and monitored regularly. Therefore, the increasing prevalence of heart disease and other cardiovascular diseases fuels the population's adoption of blood pressure monitors.

• According to the data published by Centers for Disease Control and Prevention (CDC), in 2023, around 795,000 suffer from stroke annually. Out of this, 610,000 are the number of individuals suffering from stroke for the first time.

During the COVID-19 pandemic in 2020, many studies showed the occurrence of hypertension in COVID-19-infected patients, which fueled the demand for regular blood pressure monitoring in COVID-19 patients. This led to increased adoption of blood pressure monitors among the general and patient population in the country during the pandemic.

LATEST TRENDS

Increasing Commercialization of Technologically Advanced Products to Boost Market Growth

The rising burden of hypertension and other cardiovascular diseases has increased the demand for efficient and continuous monitoring systems from home care settings. Market players have been focused on developing and commercializing advanced devices to fulfill these demands.

• For instance, in January 2022, Aktiia SA announced the commercialization of a 24/7 Blood Pressure Monitor, a wearable device in the U.S. With this device, physicians can regularly monitor their patients’ blood pressure.

The launch of advanced blood pressure monitoring devices with 24/7 monitoring features has increased its adoption among the U.S. population, fueling the U.S. blood pressure monitors market growth.

DRIVING FACTORS

Increasing Prevalence of Hypertension and Other Chronic Diseases Fuel Market Growth

Hypertension and other heart diseases have been increasing significantly in the U.S. Due to hypertension, the mortality rate in the U.S. has been increasing. The increasing burden of hypertension and the rising adoption of a sedentary lifestyle have been fueling the demand for these monitors in the country.

• For instance, according to the American Heart Association, an estimated 46.0% of U.S. adults suffer from hypertension yearly. In 2021, hypertension contributed to 691,095 deaths in the U.S.


• Moroever, according to the Centers for Disease Control and Prevention (CDC), in 2020, out of the total adults suffering from hypertension, 45.0% of them suffered from uncontrolled hypertension.

Moreover, U.S. blood pressure monitors market players have also increased their focus on adopting advanced technology in their devices. These key factors have been fueling the market growth in the country.

In 2022, around 38.0 million adults had diabetes. Similarly, around 122.2 million people suffered from hypertension in the same year.

RESTRAINING FACTORS

Limitations Associated with the Use of Blood Pressure Monitors Negatively Impact the Market Growth

Hypertension is one of the most powerful modifiable risk factors for cardiovascular disease. However, certain limitations associated with using these devices include limited accuracy in calibration and lack of nocturnal recording in home blood pressure monitoring devices.

Due to this, many people assume it to be unreliable. Such factors associated with the use of these devices, along with the low awareness regarding these devices, have been limiting their adoption in the country.

SEGMENTATION

By Product Analysis

Based on product, the market is classified into sphygmomanometers, digital blood pressure monitors, and ambulatory BP monitors.

Digital BP monitors dominated the market in 2022. The segment's dominance is attributed to the increased market player’s focus on launching new advanced digital BP monitors. In February 2022, InBody announced the launch of BP 170, a digital automatic blood pressure monitoring device, to expand its offerings in the market.

By End-user Analysis

On the basis of end-user, the market is segmented into hospitals & clinics, home healthcare, and others.

The home healthcare segment dominated the U.S. market in 2022 and is expected to grow at a significant CAGR. The segment's growth is attributed to the increasing adoption of digital blood pressure monitoring devices at homecare settings for continuous patient monitoring. Moreover, the emergence of wearable blood pressure monitoring devices also boosts the segment’s growth.

KEY INDUSTRY PLAYERS

Market players, such as Omron Healthcare, Inc., Hill-Rom Holdings, Inc., and Nihon Kohden Corporation, accounted for a significant U.S. blood pressure monitors market share in 2022. The strong emphasis of market players on inorganic strategies, such as acquisitions and partnerships, is driving their growth in the market.

Other players in the market include Koninklijke Philips N.V., Masimo, GE Healthcare (General Electric Company), and American Diagnostic Corporation. Companies, such as Koninklijke Philips N.V. are focused on mergers and partnerships to develop advanced monitoring devices.

• For instance, in January 2021, Koninklijke Philips N.V. and Rennes University Hospital partnered to develop advanced patient monitoring devices.

LIST OF KEY COMPANIES PROFILED:

• Omron Healthcare, Inc. (Japan)


• Hill-Rom Holdings, Inc. (U.S.)


• Nihon Kohden Corporation (Japan)


• Koninklijke Philips N.V. (Netherlands)


• Masimo (U.S.)


• Beurer GmbH (Germany)


• GE Healthcare (General Electric Company) (U.S.)


• American Diagnostic Corporation (U.S.)


• SunTech Medical, Inc. (U.S.)

KEY INDUSTRY DEVELOPMENTS:

• September 2022 – Garmin Ltd. announced the commercialization of the Food and Drug Administration (FDA) cleared smart blood pressure monitor, Index BPM.


• March 2021 – Beurer GmbH announced the key features of the BC 51 wrist blood pressure monitor, which has different signals to measure blood pressure accurately and has a memory storage capacity of up to 120 measures.


• January 2021 – Philips partnered with Rennes University Hospital, France, to develop and innovate equipment for patient monitoring. The collaboration will also fund French start-up companies with innovative ideas.

REPORT COVERAGE

The market report provides a detailed analysis of the market. It focuses on key aspects such as an overview of technological advancements, the prevalence of hypertension in the U.S., and pricing analysis. Additionally, it includes an overview of the reimbursement scenario for the devices, new product launches, key industry developments such as mergers, partnerships, & acquisitions, and the impact of COVID-19 on the market. Besides this, the report also offers insights into the market trends and highlights key industry dynamics. In addition to the aforementioned factors, it encompasses several factors that have contributed to the growth of the market over recent years.

Report Scope & Segmentation